Related Experiment Video
Updated: Sep 10, 2025
08:50
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
859
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles.
Viswanathan Sundaram1, Santosh Aryal1
1Department of Pharmaceutical Sciences and Health Outcomes, The Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler, Tyler, Texas, USA.
Summary
Biomimetic nanoparticles, combining extracellular vesicles (EVs) and synthetic systems, offer advanced nanomedicine solutions. This integration enhances drug delivery and diagnostics by leveraging natural targeting with synthetic stability.
Area of Science:
- Nanotechnology Approaches to Biology
- Nanoscale Systems in Biology
- Nanomedicine for Oncologic Disease
Background:
- Extracellular vesicles (EVs) offer biomimetic advantages for nanomedicine but face limitations in yield and stability.
- Synthetic nanoparticles (NPs) provide stability and scalability but lack inherent targeting capabilities.
- Combining EVs and synthetic NPs creates hybrid biomimetic NPs with enhanced therapeutic potential.
Purpose of the Study:
- To review methodologies for integrating EVs with synthetic NPs.
- To address limitations of both EVs and synthetic NPs through a hybrid approach.
- To explore the clinical applications of EV-derived biomimetic NPs.
Main Methods:
- Examination of various EV sources (erythrocytes, leukocytes, cancer cells, stem cells).
- Analysis of critical procedures: EV separation, coating, and material integration.
- Assessment of scalability, membrane stability, and functional preservation.
Main Results:
- EV-synthetic NP hybrids overcome individual system shortcomings.
- Diverse EV sources provide unique biological benefits for tailored applications.
- Methodologies are evaluated for scalability and functional integrity.
Conclusions:
- EV-derived biomimetic NPs represent a promising advancement in nanomedicine.
- Hybrid systems offer improved targeted drug delivery, immunotherapy, and diagnostics.
- Further research is needed to optimize production and clinical translation.
